INVESTIGATION OF CHROMOSOMAL ABNORMALITIES INVOLVING CHROMOSOMES 12 AND 21 IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA BY KARYOTYPING AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH)

Sỹ Luân Cao1,2, Kim Thạnh Phạm1, Nguyễn Kim Dung Lê1, Thị Xinh Phan1,3,
1 Bệnh viện Truyền máu Huyết học
2 Đại học Cửu Long
3 Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Abstract

Objective: This study aimed to investigate chromosomal abnormalities involving chromosomes 12 and 21 in childhood acute lymphoblastic leukemia (ALL) using karyotyping and fluorescence in situ hybridization (FISH).


Study design: A retrospective cross-sectional case series.


Study setting and period: The study was conducted at the Blood Transfusion and Hematology Hospital from January 2023 to December 2025.


Study population: Pediatric patients (<16 years of age) diagnosed with acute lymphoblastic leukemia (ALL) based on bone marrow examination and immunophenotyping by flow cytometry. Peripheral blood and/or bone marrow samples were analyzed for abnormalities involving chromosome regions 12p13 and 21q22 using conventional cytogenetic analysis (karyotyping) and fluorescence in situ hybridization (FISH).


Results: Among a total of 184 pediatric ALL cases analyzed, chromosomal abnormalities were detected in 85 cases (46.2%) by karyotyping, whereas FISH identified abnormalities involving chromosomes 12 and 21 in 106 cases (57.6%). Among 99 cases (53.8%) with normal karyotypes, 28 cases showed abnormalities of chromosomes 12 and 21 by FISH. Specifically, 15 cases (15.1%) exhibited numerical signal abnormalities at 12p13 and 21q22, including 14 cases (14.1%) with signal amplification of 12p13 and/or 21q22 and 1 case (1.0%) with deletion of 12p13. Additionally, 13 cases (13.1%) showed the translocation t(12;21)(p13;q22), as detected by FISH. Among 78 cases (42.8%) with no detectable abnormalities at 12p13 and 21q22 by FISH, 6 cases (7.7%) had abnormalities involving other chromosomes, and 1 case (1.3%) showed abnormalities related to chromosomes 12 and 21 but not at loci 12p13 or 21q22.


Conclusion: The findings indicate that both karyotyping and FISH have distinct advantages and certain limitations in detecting chromosomal abnormalities. Therefore, the combined use of karyotyping and FISH—two complementary techniques—is essential to avoid missed abnormalities and has significant value in supporting the diagnosis of childhood ALL.

Article Details

References

1. Kumar CM, Sharma N, Reddy P, Mehta S, Manju M, Vyas A, et al. Cytogenetic abnormalities in pediatric acute lymphoblastic leukemia- retrospective study from a tertiary care center in Eastern India. Pediatr Hematol Oncol J. 2025;10:100492.
2. Senthilprabhu R, Aruna R, Ravichandran C. Cytogenetic and molecular aberrations in childhood B lineage acute lymphoblastic leukaemia. Int J Contemp Pediatr. 2020 Mar;7(3):511-515.
3. Kim KH, Kim MS, Kim YG, Han KJ, Lim IS, Lyu CJ, et al. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci. 2005 Feb;20(1):36-41.
4. Harrison CJ. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev. 2001 Mar;15(1):49-59. doi: 10.1054/blre.2001.0149.
5. Lejman M, Styka B, Zawitkowska J, Pastwańska A, Studniak E, Skonieczka K, et al. Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia - a polish paediatric population treated according to ALL-IC BFM 2009 protocol. Sci Rep. 2025;15:27589.
6. Martínez-Ramírez A, Urioste M, Contra T, Cantalejo A, Tavares A, Portero JA, et al. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphoblastic leukemia.
7. Camuset M, Le Calvez B, Theisen O, Godon C, Grain A, Thomas C, et al. Added value of molecular karyotype in childhood acute lymphoblastic leukemia. Cancer Innov. 2023;2(3):192-201.